zepbound/mounjaro/tirzepatide FDA approves Zepbound for weight loss FDA approval for Zepbound (tirzepatide)

This may reduce follicle sensitivity to DHT without systemic hormonal effects, avoiding the sexual side effects associated with finasteride while still protecting hair follicles from androgen damage

No changes have been made to the meals themselves the badge simply highlights existing products that are well-suited to GLP-1 users

This triagonist profile differentiates retatrutide from existing anti-obesity therapies such as semaglutide, a GLP-1 receptor agonist, and tirzepatide, a dual GLP-1/GIP agonist, both of which lack glucagon receptor activity (Hamrick et al., 2024)

The plan covers medication, physician oversight, free shipping, and unlimited telehealth check-ins